Search Results 7131-7140 of 26478 for oral

1. A Phase 1b/2 Study of Onvansertib (PCM-075) in Combination with FOLFIRI and Bevacizumab for Second-Line Treatment of Metastatic Colorectal Cancer in Patients with a KRAS Mutation - Mayo Clinic

   Gastrointestinal (GI) disorder(s) that, in the opinion of the Investigator, would significantly impede the absorption of an oral agent (e.g., intestinal ...

2. Testing The Addition Of An Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery To The Usual Surgery Alone For Treating Advanced Skin Cancer - Mayo Clinic

   ... oral, sinonasal, conjunctival, anogenital). Tumor must be resectable with curative intent. Note: Tumor with bony skull base invasion and/or skull base ...

3. A Study to Evaluate the Effectiveness and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma - Mayo Clinic

   Inability of the participant to swallow and retain oral medication; Clinically significant or uncontrolled cardiac disease, including unstable angina, acute ...

4. A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Patients - Mayo Clinic

   Subjects will be randomized 2:1 to orally self-administer blinded treatment: MMB plus placebo or DAN plus placebo. Subjects randomized to receive MMB who ...

5. Basal cell carcinoma - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Pediatric Hematology/Oncology. Doctors who treat this condition. Edit search filters. close. Narrow your search. By location.

6. Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors - Mayo Clinic

   Subjects with any condition that may impair the ability to swallow or absorb oral medications/investigational product including: Any lesion, whether induced ...

7. Robotic surgery - Doctors & Departments - Mayo Clinic

   ... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...

8. Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies - Mayo Clinic

   Presence of a dental, oral, or facial condition which, in the Treating Investigator's opinion, would interfere with the study injections and/or study ...

9. A Study to Evaluate Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having Heart Failure with Preserved Ejection Fraction - Mayo Clinic

   Treatment with intravenous (IV) diuretics, or intensification of oral diuresis for HF in a healthcare facility within the 12 months prior to study entry;; NT ...

10. Early Feasibility Study - Transcatheter Atrial Shunt System - Mayo Clinic

    ... oral diuresis for HF in a healthcare facility (emergency department/acute care facility) within the 12 months prior to study entry; OR an NT-pro BNP value ...